BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1150 related articles for article (PubMed ID: 12566312)

  • 21. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
    Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
    Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
    Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
    Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
    Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
    Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
    Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
    Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
    J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage-specific expression of breast cancer-specific gene gamma-synuclein.
    Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.
    Inaba S; Li C; Shi YE; Song DQ; Jiang JD; Liu J
    Breast Cancer Res Treat; 2005 Nov; 94(1):25-35. PubMed ID: 16142440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression.
    Lin J; Lai M; Huang Q; Ma Y; Cui J; Ruan W
    J Pathol; 2007 May; 212(1):83-90. PubMed ID: 17334979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
    Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
    Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
    Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.
    Dokun OY; Florl AR; Seifert HH; Wolff I; Schulz WA
    Int J Cancer; 2008 Dec; 123(12):2798-807. PubMed ID: 18803290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
    Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
    Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.